US 9657090
Method of treating alveolar bone loss through the use of anti-sclerostin antibodies
granted A61KA61K2039/505A61K39/3955
Quick answer
US patent 9657090 (Method of treating alveolar bone loss through the use of anti-sclerostin antibodies) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE REGENTS OF THE UNIVERSITY OF MICHIGAN
- Grant date
- Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/505, A61K39/3955, A61K45/06, A61P